Dheerajnag Nelanutala
Strategy consultant with global experience advising Fortune 500 biopharma clients on transaction advisory and partnership strategy. Skilled in corporate finance with expertise in due diligence, financial modelling and valuation supporting investment decision-making.
Work Experience:
4.8 Years
Industry:
Consulting | Pharmaceutical & Healthcare
Function:
Consulting & Strategy | Finance | Investments
Work Experience
ZS Associates (Global management consulting and technology firm) | Pune
Advisory Consultant (Transaction Advisory)
- Advised senior leadership of a top-10 pharmaceutical company on in-house versus partnership strategy across 18 markets and 177 brands, identifying opportunities for ~$50M in operating income uplift
- Supported proposal development and client acquisition efforts with biopharma and private equity clients, contributing to engagements valued at $800K
- Led cross-functional consulting teams of 4–6 members across geographies, ensuring seamless delivery while supporting career progression initiatives for 5 junior colleagues
Decision Analytics Associate Consultant
- Conducted 10+ M&A and due diligence engagements for healthcare clients, developing forecasts and valuation models supporting transactions exceeding $1B in aggregate value
- Performed financial analysis of 20+ target assets to evaluate potential value across acquisition, co-promotion, and co-development structures
- Developed royalty restructuring strategies for a multibillion-dollar pharmaceutical asset, projecting a 10–15% increase in operating income across ex-U.S. markets
- Led U.S. commercial diligence for a specialty therapy asset by developing TAM, patient funnel, access, and multi-scenario revenue forecasts to inform investment decisions and valuation for a potential billion-dollar drug
- Designed and implemented a go-to-market accelerator tool with reusable forecasting, field force sizing, and commercial cost templates, reducing project turnaround time by 30%
Decision Analytics Associate
- Supported the development of an inorganic growth strategy for top biopharma companies by analysing ~$100B of global pharmaceutical M&A activity spanning two decades, contributing to ~$2M in new business opportunities
- Developed patient-based forecasting and DCF valuation models to quantify market opportunities and assess strategic fit across therapeutic areas and asset classes
- Developed sales force sizing, HCP coverage, and P&L models across European pharmaceutical markets, informing commercial planning and resource allocation decisions
- Independently developed an automated launch-planning tool that reduced manual effort by 60% and improved project profitability by ~10%
Accomplishments
- Promoted to Advisory Consultant ahead of schedule after consistently taking on responsibilities beyond role expectations, including team leadership and senior stakeholder engagement
- Recipient of 3+ Impact Awards at ZS for delivering high-impact engagements and driving exceptional outcomes for global healthcare clients
- Recognized with a firm-level GenAI Adoption Award for introducing AI-enabled approaches to financial modelling and commercial forecasting, reducing analysis turnaround time
Education
- Bachelor of Technology (Major in Metallurgical & Materials Engineering and Minor in Management), National Institute of Technology, Tiruchirappalli
Certification
- Financial Modelling and Valuation Analyst (FMVA) by Corporate Finance Institute
- Financial Markets by Yale
- Excel Skills for Business: Advanced by Macquarie University
Extra-curricular
- Led a team of 12 students to develop a comprehensive course for 3rd-year B.Tech. students, emphasizing industry-relevant skill acquisition by establishing a feedback and progress tracking system to enhance learning outcomes and facilitate continuous improvement
- Led the publicity team of the first online edition of Mettle, the annual symposium of NIT Trichy’s Metallurgical Engineering Dept., by expanding to multiple social media platforms and driving engagement through active digital outreach